Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly Alzheimer's Study Change Piles Risk on Top of Risk
Lilly Alzheimer's Study Change Piles Risk on Top of Risk
Lilly Alzheimer's Study Change Piles Risk on Top of Risk
Submitted by
admin
on March 15, 2016 - 10:18pm
Source:
TheStreet.com
News Tags:
Eli Lilly
Alzheimer's disease
solanezumab
clinical trials
Headline:
Lilly Alzheimer's Study Change Piles Risk on Top of Risk
Do Not Allow Advertisers to Use My Personal information
